Hiroshi Date
About
Hiroshi Date is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology.
According to data from OpenAlex, Hiroshi Date has authored 762 papers receiving a total of 14.9k indexed citations (citations by other indexed papers that have themselves been cited), including 447 papers in Pulmonary and Respiratory Medicine, 392 papers in Surgery and 199 papers in Oncology. Recurrent topics in Hiroshi Date's work include Transplantation: Methods and Outcomes (283 papers), Organ Transplantation Techniques and Outcomes (155 papers) and Lung Cancer Diagnosis and Treatment (147 papers). Hiroshi Date is often cited by papers focused on Transplantation: Methods and Outcomes (283 papers), Organ Transplantation Techniques and Outcomes (155 papers) and Lung Cancer Diagnosis and Treatment (147 papers). Hiroshi Date collaborates with scholars based in Japan, United States and United Kingdom. Hiroshi Date's co-authors include Motoi Aoe, Nobuyoshi Shimizu, Shinichi Toyooka, Makoto Sonobe, Yoshifumi Sano, Fengshi Chen, Toru Bando, Toyofumi F. Chen‐Yoshikawa, Katsuyuki Kiura and Akio Andou and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Journal of Clinical Oncology.
In The Last Decade
Hiroshi Date
720 papers receiving 14.7k citations
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Hiroshi Date Japan | 59 | 9.0k | 4.8k | 4.2k | 2.5k | 1.4k | 762 | 14.9k | ||
| Walter Weder Switzerland | 62 | 9.7k 1.1× | 3.9k 0.8× | 3.0k 0.7× | 1.5k 0.6× | 918 0.7× | 434 | 15.4k | ||
| Piotr Rutkowski Poland | 65 | 7.9k 0.9× | 3.2k 0.7× | 8.8k 2.1× | 4.9k 2.0× | 1.3k 0.9× | 912 | 20.3k | ||
| Hartwig Huland Germany | 73 | 11.7k 1.3× | 4.2k 0.9× | 2.8k 0.7× | 3.0k 1.2× | 2.2k 1.6× | 613 | 17.5k | ||
| Akimasa Nakao Japan | 62 | 4.1k 0.4× | 6.0k 1.3× | 7.3k 1.7× | 3.7k 1.5× | 2.2k 1.6× | 554 | 15.2k | ||
| Ken Shirabe Japan | 62 | 2.8k 0.3× | 6.7k 1.4× | 4.8k 1.2× | 2.7k 1.1× | 2.4k 1.7× | 859 | 17.4k | ||
| Marianna Zahurak United States | 69 | 5.0k 0.6× | 5.7k 1.2× | 6.8k 1.6× | 3.5k 1.4× | 2.1k 1.5× | 221 | 16.8k | ||
| Takehiko Fujisawa Japan | 59 | 7.2k 0.8× | 1.9k 0.4× | 4.8k 1.2× | 2.3k 0.9× | 1.1k 0.8× | 261 | 12.2k | ||
| Keiichi Kubota Japan | 46 | 2.5k 0.3× | 4.1k 0.9× | 3.3k 0.8× | 818 0.3× | 1.3k 0.9× | 397 | 9.5k | ||
| R. Houston Thompson United States | 69 | 12.6k 1.4× | 5.5k 1.2× | 4.8k 1.2× | 7.6k 3.0× | 2.3k 1.6× | 424 | 18.5k | ||
| Michael A.S. Jewett Canada | 69 | 8.9k 1.0× | 6.1k 1.3× | 2.0k 0.5× | 6.5k 2.6× | 2.5k 1.7× | 418 | 15.7k |
Countries citing papers authored by Hiroshi Date
Since
Specialization
Citations
This map shows the geographic impact of Hiroshi Date's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Date with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Date more than expected).
Fields of papers citing papers by Hiroshi Date
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Hiroshi Date. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Date. The network helps show where Hiroshi Date may publish in the future.
Co-authorship network of co-authors of Hiroshi Date
This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Date. A scholar is included among the top collaborators of Hiroshi Date based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Date. Hiroshi Date is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Ikeda, Masaki, Akihiro Aoyama, Masanori Okuda, et al.. (2024). Beneficial effects of extracorporeal membrane oxygenation over cardiopulmonary bypass in living-donor lobar lung transplantation. SHILAP Revista de lepidopterología. 4. 100070–100070.
2.
Nakajima, Daisuke, Hidenao Kayawake, Satona Tanaka, et al.. (2023). The first successful case of ABO-incompatible living-donor lobar lung transplantation following desensitization therapy. American Journal of Transplantation. 23(9). 1451–1454.
3.
Yutaka, Yojiro, Satona Tanaka, Yoshito Yamada, et al.. (2022). Fissure-last technique for left upper lobe lung cancer with interlobar invasion: how to do it?. General Thoracic and Cardiovascular Surgery. 70(9). 828–831.
4.
Yutaka, Yojiro, Akihiro Ohsumi, Daisuke Nakajima, et al.. (2022). Intraoperative margin assessment by wireless signals in thoracoscopic anterior (S3) segmentectomy using a radiofrequency identification marker. General Thoracic and Cardiovascular Surgery. 70(5). 509–513.
5.
Murakami, Kōtaro, Yojiro Yutaka, Naoki Nakajima, Akihiko Yoshizawa, & Hiroshi Date. (2020). Ciliated muconodular papillary tumor with a growing cavity shadow that mimicked colorectal metastasis to the lung: a case report. SHILAP Revista de lepidopterología. 6(1). 231–231.
6.
Satō, Toshihiko, Akinori Iwasaki, Yojiro Yutaka, et al.. (2020). Is left-side DaVinci™ procedure challenging? Initial experiences of a single institute. General Thoracic and Cardiovascular Surgery. 68(11). 1285–1289.
7.
Nishikawa, Shigeto, Toshi Menju, Koji Takahashi, et al.. (2019). <p>Statins may have double-edged effects in patients with lung adenocarcinoma after lung resection</p>. Cancer Management and Research. Volume 11. 3419–3432.
8.
Chen‐Yoshikawa, Toyofumi F., Satona Tanaka, Yoshito Yamada, et al.. (2019). Intermediate outcomes of right-to-left inverted living-donor lobar lung transplantation. European Journal of Cardio-Thoracic Surgery. 56(6). 1046–1053.
9.
Yoshizawa, Akihiko, Shinji Sumiyoshi, Makoto Sonobe, et al.. (2016). Lung Adenocarcinoma With MUC4 Expression Is Associated With Smoking Status, HER2 Protein Expression, and Poor Prognosis: Clinicopathologic Analysis of 338 Cases. Clinical Lung Cancer. 18(4). e273–e281.
10.
Ando, Takeshi, Mitsugu Omasa, Takayuki Kondo, et al.. (2015). Predictive factors of myasthenic crisis after extended thymectomy for patients with myasthenia gravis. European Journal of Cardio-Thoracic Surgery. 48(5). 705–709.
11.
Chen, Fengshi, Yuji Nakamoto, Takeshi Kondo, et al.. (2014). Gastroparesis after living-donor lobar lung transplantation: report of five cases. Surgery Today. 45(3). 378–382.
12.
Nagao, Miki, Satoshi Nakano, Masaki Yamamoto, et al.. (2014). Itraconazole prophylaxis for invasive A spergillus infection in lung transplantation. Transplant Infectious Disease. 16(2). 340–343.
13.
Satō, Toshihiko, Satoshi Teramukai, Haruhiko Kondo, et al.. (2013). Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer. Journal of Thoracic and Cardiovascular Surgery. 147(5). 1604–1611.e3.
14.
Yoshizawa, Akihiko, Shinji Sumiyoshi, Makoto Sonobe, et al.. (2012). Validation of the IASLC/ATS/ERS Lung Adenocarcinoma Classification for Prognosis and Association with EGFR and KRAS Gene Mutations: Analysis of 440 Japanese Patients. Journal of Thoracic Oncology. 8(1). 52–61.
15.
Ishikawa, Masashi, Ryo Miyahara, Makoto Sonobe, et al.. (2012). Higher expression of EphA2 and ephrin-A1 is related to favorable clinicopathological features in pathological stage I non-small cell lung carcinoma. Lung Cancer. 76(3). 431–438.
16.
Menju, Toshi, Shigeru Hashimoto, Ari Hashimoto, et al.. (2011). Engagement of Overexpressed Her2 with GEP100 Induces Autonomous Invasive Activities and Provides a Biomarker for Metastases of Lung Adenocarcinoma. PLoS ONE. 6(9). e25301–e25301.
17.
Sonobe, Makoto, Fengshi Chen, Takuji Fujinaga, et al.. (2009). Use of totally implantable central venous access port via the basilic vein in patients with thoracic malignancies. International Journal of Clinical Oncology. 14(3). 208–212.
18.
Kanzaki, Hirotaka, Mamoru Ouchida, Hiroko Hanafusa, et al.. (2007). The association between RAD18 Arg302Gln polymorphism and the risk of human non-small-cell lung cancer. Journal of Cancer Research and Clinical Oncology. 134(2). 211–217.
19.
Tokumo, Masaki, Shinichi Toyooka, Shuji Ichihara, et al.. (2006). Double mutation and gene copy number of EGFR in gefitinib refractory non-small-cell lung cancer. Lung Cancer. 53(1). 117–121.
20.
Date, Hiroshi, et al.. (2002). Two Test Generation Methods Using a Compacted Test Table and a Compacted Test Plan Table for RTL Data Path Circuits. IEICE Transactions on Information and Systems. 85(10). 1474–1482.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Walter Weder Breakdown of academic impact, for papers by Piotr Rutkowski Breakdown of academic impact, for papers by Hartwig Huland Breakdown of academic impact, for papers by Akimasa Nakao Breakdown of academic impact, for papers by Ken Shirabe Breakdown of academic impact, for papers by Marianna Zahurak Breakdown of academic impact, for papers by Takehiko Fujisawa Breakdown of academic impact, for papers by Keiichi Kubota Breakdown of academic impact, for papers by R. Houston Thompson Breakdown of academic impact, for papers by Michael A.S. Jewett